Fosfomycin-associated adverse events: A disproportionality analysis of the FDA Adverse Event Reporting System
{{output}}
Fosfomycin, with its unique mechanism of action, has emerged as a promising option for clinicians to combat antimicrobial resistance and the limited availability of effective drugs, which has led to an increase in associated adverse events (AEs). This study ai... ...
